The pharmaceuticals industry is fiercely competitive, subject to intense regulation and highly dependent upon work carried out at the R&D stage. Identification, protection and exploitation of intellectual property rights is vital to our clients’ success.
Our pharma team is highly knowledgeable about the process of development, testing and commercialisation of pharmaceutical products and their entire lifecycle.
Most of the fee-earners in our pharma team have a life-sciences degree. Each team member also has deep sectoral knowledge of the pharmaceutical and medical devices industry and so is particularly well placed to advise national and international companies on all aspects of the industry.
By drawing on the expertise of our highly respected intellectual property, corporate and dispute resolution groups, the team delivers an award-winning, high-quality and multi-disciplinary service.
For more information on pharmaceutical law click here.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world